Robert T. Eagan

2.9k total citations · 1 hit paper
72 papers, 2.3k citations indexed

About

Robert T. Eagan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Robert T. Eagan has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 19 papers in Epidemiology. Recurrent topics in Robert T. Eagan's work include Lung Cancer Research Studies (30 papers), Lung Cancer Treatments and Mutations (28 papers) and Neuroendocrine Tumor Research Advances (18 papers). Robert T. Eagan is often cited by papers focused on Lung Cancer Research Studies (30 papers), Lung Cancer Treatments and Mutations (28 papers) and Neuroendocrine Tumor Research Advances (18 papers). Robert T. Eagan collaborates with scholars based in United States, France and Netherlands. Robert T. Eagan's co-authors include Peter C. Pairolero, Stephen Frytak, Robert J. Ginsberg, Clifton F. Mountain, Lucius D. Hill, Thomas R. Fleming, Edward T. Creagan, R. Jackson Forcier, L. Herbert Maurer and James R. Jett and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Robert T. Eagan

72 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modern thirty-day operative mortality for surgical resections in lung cancer

1983 511 citations Robert J. Ginsberg, Lucius D. Hill et al. Journal of Thoracic and Cardiovascular Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert T. Eagan United States	24	1.5k	1.1k	436	289	268	72	2.3k
Louis A. Leone United States	26	582 0.4×	1.2k 1.1×	372 0.9×	297 1.0×	352 1.3×	59	2.4k
Don V. Jackson United States	27	508 0.3×	1.3k 1.2×	251 0.6×	219 0.8×	337 1.3×	75	2.0k
A. Philippe Chahinian United States	21	1.1k 0.7×	1.0k 0.9×	571 1.3×	208 0.7×	268 1.0×	42	2.1k
G Dabouis France	21	1.5k 1.0×	1.5k 1.3×	267 0.6×	161 0.6×	450 1.7×	69	2.3k
Dorothy Watson United States	17	2.3k 1.5×	1.8k 1.6×	302 0.7×	159 0.6×	374 1.4×	31	3.1k
Norio Mitsuhashi Japan	28	1.4k 0.9×	583 0.5×	227 0.5×	888 3.1×	388 1.4×	188	2.8k
Paolo Bidoli Italy	27	1.9k 1.2×	2.0k 1.8×	190 0.4×	365 1.3×	531 2.0×	127	3.1k
Luigi Manzione Italy	29	1.3k 0.8×	2.4k 2.2×	186 0.4×	637 2.2×	386 1.4×	88	3.4k
Young Hak Kim Japan	30	1.7k 1.1×	1.9k 1.7×	292 0.7×	225 0.8×	644 2.4×	127	2.8k
R Joss Switzerland	21	994 0.6×	1.6k 1.5×	894 2.1×	289 1.0×	479 1.8×	89	2.2k

Countries citing papers authored by Robert T. Eagan

Since Specialization

Citations

This map shows the geographic impact of Robert T. Eagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Eagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Eagan more than expected).

Fields of papers citing papers by Robert T. Eagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Eagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Eagan. The network helps show where Robert T. Eagan may publish in the future.

Co-authorship network of co-authors of Robert T. Eagan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Eagan. A scholar is included among the top collaborators of Robert T. Eagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Eagan. Robert T. Eagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bonner, James A., Robert T. Eagan, Stephen Frytak, et al.. (1995). Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer. Cancer. 76(3). 406–412. 6 indexed citations

Bonner, James A., Edward G. Shaw, Stephen Frytak, et al.. (1995). Prophylactic cranial irradiation in limited-stage small cell lung cancer. Cancer. 75(6). 1302–1309. 8 indexed citations

Shaw, Edward G., et al.. (1994). Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.. Journal of Clinical Oncology. 12(11). 2327–2332. 45 indexed citations

Robinow, Jay S., Edward G. Shaw, Robert T. Eagan, et al.. (1989). Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 17(6). 1203–1210. 36 indexed citations

Frytak, Stephen, Brian Patrick O’Neill, Robert T. Eagan, et al.. (1989). Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation. American Journal of Clinical Oncology. 12(1). 27–33. 72 indexed citations

Frytak, Stephen, et al.. (1988). Treatment of “Limited” Stage III Non-Small Cell Carcinoma of the Lung. Cancer Investigation. 6(2). 193–207. 6 indexed citations

Frytak, Stephen, Robert T. Eagan, Edward G. Shaw, et al.. (1988). Treatment Toxicities in Long-Term Survivors of Limited Small Cell Lung Cancer. Cancer Investigation. 6(6). 669–676. 13 indexed citations

Eagan, Robert T., Stephen Frytak, Ronald L. Richardson, et al.. (1988). A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.. Journal of Clinical Oncology. 6(1). 5–8. 16 indexed citations

Eagan, Robert T., et al.. (1987). Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer.. PubMed. 71(10). 895–900. 67 indexed citations

10.

Sorensen, Scot, et al.. (1984). Meningeal Carcinomatosis in Patients With Primary Breast or Lung Cancer. Mayo Clinic Proceedings. 59(2). 91–94. 58 indexed citations

11.

Eagan, Robert T., Philip E. Bernatz, W. Spencer Payne, et al.. (1984). Pleural lavage after pulmonary resection for bronchogenic carcinoma. Journal of Thoracic and Cardiovascular Surgery. 88(6). 1000–1003. 39 indexed citations

12.

Eagan, Robert T., et al.. (1983). Preliminary communication — Treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ; NSC-182986). American Journal of Clinical Oncology. 6(5). 577–578. 7 indexed citations

13.

Ginsberg, Robert J., Lucius D. Hill, Robert T. Eagan, et al.. (1983). Modern thirty-day operative mortality for surgical resections in lung cancer. Journal of Thoracic and Cardiovascular Surgery. 86(5). 654–658. 511 indexed citations breakdown →

14.

Kovach, J. S., Robert T. Eagan, Garth Powis, et al.. (1982). Phase I and pharmacokinetic studies of DON.. PubMed. 65(11-12). 1031–6. 22 indexed citations

15.

Eagan, Robert T., Stephen Frytak, Edward T. Creagan, et al.. (1979). Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(9-10). 1589–91. 18 indexed citations

16.

Ames, Matthew M., Garth Powis, John S. Kovach, & Robert T. Eagan. (1979). Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.. PubMed. 39(12). 5016–21. 35 indexed citations

17.

Eagan, Robert T., Robert Lee, Stephen Frytak, et al.. (1979). Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 5(8). 1401–1405. 23 indexed citations

18.

Eagan, Robert T., Edward T. Creagan, James N. Ingle, et al.. (1979). VP-16, Cyclophosphamide, Adriamycin and Cis-platinum (V:CAP-I) in Patients with Metastatic Adenocarcinoma of the Lung. Tumori Journal. 65(1). 105–109. 8 indexed citations

19.

Eagan, Robert T., J. N. Ingle, Jonah Rubin, Stephen Frytak, & C G Moertel. (1978). Early Clinical Study of an Intermittent Schedule for Maytansine (NSC-153858): Brief Communication 2. JNCI Journal of the National Cancer Institute. 60(1). 93–96. 28 indexed citations

20.

Coleman, Michael F., et al.. (1977). Piperazinedione in metastatic renal carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(9). 1731–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact